Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense,...
Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense,...
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM...
The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as...
Program invites donors, health institutions, and care providers to join movement for equitable healthcare access LOS ANGELES, Sept. 18, 2025...
The new site solution enables centralized referral management, real-time trial updates and enhanced physician communication to improve patient retention for...
AUSTIN, Texas and TOKYO, Sept. 18, 2025 /PRNewswire/ -- According to DataM Intelligence, the global AI in remote patient monitoring market...
First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months)...
Trusted Partnership Connects HIPAA Compliance Leader with Specialized EMR/EHR Provider for Integrative Medicine HUNTINGTON, N.Y. and NASHVILLE, Tenn., Sept. 18,...
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital...
Collaboration highlights CaduceusHealth's commitment to enhance client financial health for AthenaHealth customers by adopting cutting-edge technologies. NEW YORK, Sept. 17,...
Hyro's responsible AI agents empower Sutter's patients with seamless self-service capabilities across voice, chat and SMS— helping drive better access...
SAN FRANCISCO, CA AND BRENTWOOD, TN / ACCESS Newswire / September 17, 2025 / Ardent Health, a leading provider of...
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA ApprovalKANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE)...
Research Triangle Park, N.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Final participant randomized to complete enrollment in Phase 1 clinical...
TRUE-See Expands Its AI Clinical Leadership Capabilities with Addition of Dr. Peter Chang as Senior AI AdvisorNEW ORLEANS, Sept. 17,...
Recognition by Healthcare Tech Outlook underscores Glytec's leadership in hospital insulin management, clinical outcomes, and enterprise scalability BOSTON, Sept. 16,...
Ahead of MEDITECH LIVE 2025 this week, Black Book releases survey findings from 128 hospital clients, conducted prior to the...
Healthcare leaders are rethinking tech investments to safeguard revenue, improve efficiency, and ensure compliance amid reimbursement and interoperability uncertainty PITTSBURGH,...
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global connected...
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people...